Pulmonary Hypertension (PH): A Patient’s Experience
Pulmonary Hypertension (PH): A Patient’s Experience is organized by Canadian Cardiovascular Society (CCS) and will be held from Jan 02, 2023 - Jun 30, 2025.
Available Until: June 2025
Program description:
This series is a multipronged evidence and needs-based Knowledge to Action (KTA) strategy that merges, scales, and improves upon the Canadian Cardiovascular Society (CCS) Pulmonary Hypertension KT program and the Canadian Society of Echocardiography (CSE) Step Right Up program.
This 3-part program presents multi-pronged evidence and a needs-based Knowledge to Action (KTA) strategy that merges, scales and improves upon the CCS’s Pulmonary Hypertension KT program and the CSE’s Step Up program, with a focus on the medical and imaging aspects of PH.
Learning Objectives:
CanMEDS roles relevant to this activity: Medical Expert, Communicator, Collaborator, Health advocate, Scholar
Overall Learning Objectives
• Promote awareness of pulmonary hypertension (PH) as a possible diagnosis when patients present with dyspnea (Medical expert, Health advocate)
• Demonstrate the diagnosis and classification of PH through evidence in practice (Medical expert, Scholar)
• Relate the importance of patient-centred and team-based management, from presentation with dyspnea through testing, diagnosis and treatment (Medical expert, Communicator, Collaborator)
Individual Learning Objectives
A Case of a Patient with PH
• Describe the main symptoms, signs and physical examination findings of PH and right heart failure (Medical expert, Communicator, Collaborator)
• Describe the different diagnostic methods used to investigate a suspected PH (Medical expert, Communicator, Collaborator)
Steps to Diagnosing A Suspected PH and Case Discussion
• Correctly diagnose PH using different diagnostic tools (symptoms, patient history, imaging, etc.) (Medical expert, Communicator, Collaborator)
• Analyze and interpret basic echocardiographic findings suggestive of PH (Medical expert, Communicator, Collaborator)
• Identify high-risk populations and classify patients with suspected PH (Medical expert, Communicator, Collaborator)
• Recognize why early diagnosis of PH potentially improves patient outcomes (Medical expert, Communicator, Collaborator, Leader)
Pulmonary Hypertension: A Patient’s Experience
• Recognize the impact of PH on the quality of life of patients and caregivers beyond the clinical symptoms (Medical expert, Collaborator, Health advocate)
• Gain an understanding of the patient’s PH journey to improve patient care and disease management (Medical expert, Communicator, Leader).
Additional details will be posted as soon as information is available.